Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75


Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke.

Ali SB, Moosang M, King L, Knight-Madden J, Reid M.

Am J Hematol. 2011 Oct;86(10):846-50. doi: 10.1002/ajh.22142. Epub 2011 Sep 2.


Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.

Ware RE, Schultz WH, Yovetich N, Mortier NA, Alvarez O, Hilliard L, Iyer RV, Miller ST, Rogers ZR, Scott JP, Waclawiw M, Helms RW.

Pediatr Blood Cancer. 2011 Dec 1;57(6):1011-7. doi: 10.1002/pbc.23145. Epub 2011 Aug 8.


Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.

Berger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR.

Am Heart J. 2011 Jul;162(1):115-24.e2. doi: 10.1016/j.ahj.2011.04.006. Review.


Stroke: do statins improve outcomes after acute ischemic stroke?

Willey JZ, Elkind MS.

Nat Rev Neurol. 2011 Jun 14;7(7):364-5. doi: 10.1038/nrneurol.2011.92. No abstract available.


Stroke rehabilitation.

Langhorne P, Bernhardt J, Kwakkel G.

Lancet. 2011 May 14;377(9778):1693-702. doi: 10.1016/S0140-6736(11)60325-5. Review.


Genetic predictors for stroke in children with sickle cell anemia.

Flanagan JM, Frohlich DM, Howard TA, Schultz WH, Driscoll C, Nagasubramanian R, Mortier NA, Kimble AC, Aygun B, Adams RJ, Helms RW, Ware RE.

Blood. 2011 Jun 16;117(24):6681-4. doi: 10.1182/blood-2011-01-332205. Epub 2011 Apr 22.


A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.

Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L.

Br J Haematol. 2011 Jun;153(5):655-63. doi: 10.1111/j.1365-2141.2010.08480.x. Epub 2011 Apr 8.


Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.

Greenway A, Ware RE, Thornburg CD.

Am J Hematol. 2011 Apr;86(4):357-61. doi: 10.1002/ajh.21986.


Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.

Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research.

Stroke. 2011 Jan;42(1):227-76. doi: 10.1161/STR.0b013e3181f7d043. Epub 2010 Oct 21.


Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR.

Blood. 2011 Jan 20;117(3):772-9. doi: 10.1182/blood-2010-01-261123. Epub 2010 Oct 12.


Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, MacDonald RL, Messé SR, Mitchell PH, Selim M, Tamargo RJ; American Heart Association Stroke Council and Council on Cardiovascular Nursing.

Stroke. 2010 Sep;41(9):2108-29. doi: 10.1161/STR.0b013e3181ec611b. Epub 2010 Jul 22.


Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: A review of the literature.

Charneski L, Congdon HB.

Am J Health Syst Pharm. 2010 Jun 1;67(11):895-900. doi: 10.2146/ajhp090229. Review.


Extracranial internal carotid arterial disease in children with sickle cell anemia.

Deane CR, Goss D, Bartram J, Pohl KR, Height SE, Sibtain N, Jarosz J, Thein SL, Rees DC.

Haematologica. 2010 Aug;95(8):1287-92. doi: 10.3324/haematol.2010.022624. Epub 2010 Mar 10.


Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, Childs RW, Rodgers GP, Powell JD, Tisdale JF.

N Engl J Med. 2009 Dec 10;361(24):2309-17. doi: 10.1056/NEJMoa0904971.


Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, Buchanan GR, Bunin N, Dickerhoff R, Giller R, Haut PR, Horan J, Hsu LL, Kamani N, Levine JE, Margolis D, Ohene-Frempong K, Patience M, Redding-Lallinger R, Roberts IA, Rogers ZR, Sanders JE, Scott JP, Sullivan KM; Multicenter Study of Bone Marrow Transplantation for Sickle Cell Disease.

Biol Blood Marrow Transplant. 2010 Feb;16(2):263-72. doi: 10.1016/j.bbmt.2009.10.005. Epub 2009 Oct 12.


Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association.

Latchaw RE, Alberts MJ, Lev MH, Connors JJ, Harbaugh RE, Higashida RT, Hobson R, Kidwell CS, Koroshetz WJ, Mathews V, Villablanca P, Warach S, Walters B; American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, and the Interdisciplinary Council on Peripheral Vascular Disease.

Stroke. 2009 Nov;40(11):3646-78. doi: 10.1161/STROKEAHA.108.192616. Epub 2009 Sep 24. Review. No abstract available.


The excess burden of stroke in hospitalized adults with sickle cell disease.

Strouse JJ, Jordan LC, Lanzkron S, Casella JF.

Am J Hematol. 2009 Sep;84(9):548-52. doi: 10.1002/ajh.21476.


Will submandibular TCD prevent stroke in children with sickle cell anemia?

Jordan LC, Strouse JJ.

Neurology. 2009 Aug 4;73(5):340-1. doi: 10.1212/WNL.0b013e3181b1221e. Epub 2009 Jun 24. No abstract available.


Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis.

Lansberg MG, Bluhmki E, Thijs VN.

Stroke. 2009 Jul;40(7):2438-41. doi: 10.1161/STROKEAHA.109.552547. Epub 2009 May 28.

Supplemental Content

Support Center